Français
Deutsch
Español
Italiano
Português
日本語
한국어
Русский
Latest news
Invetech, Haemonetics, and Coramed Technologies Receive 2016 Good Design Award® for Development of the TEG® 6s
Jul 16, 2023Her Symptoms Suggested Long Covid. But Was That Too Obvious?
May 03, 2023Lysosomal
Apr 13, 2023Biochemical Reagents Market 2023 Unveiling Future Growth, Explores New Trends and Forecasts
Mar 16, 2023US FDA approves Cue Health’s at
Apr 27, 2023LUPKYNIS® Achieved Significantly Higher Renal Response in Lupus Nephritis Patients with High Proteinuria Compared to Patients Treated with MMF and Low Dose Steroids Alone
Jan 17, 2024$34.4 million in net revenue for the first quarter of 2023; an increase of 59% over the first quarter of the prior year
Increases 2023 revenue guidance range to $135 - $155 million from net product sales of LUPKYNIS
News Provided by Business Wire via QuoteMedia